Related Experiment Videos
Quinuclidin-2-ene-based muscarinic antagonists
U Hacksell1, B M Nilsson, G Nordvall
1Department of Organic Pharmaceutical Chemistry, Uppsala Biomedical Center, Uppsala University, Sweden.
Life Sciences
|January 1, 1995
Summary
Researchers synthesized novel quinuclidin-2-ene derivatives and tested their muscarinic receptor activity. Compound 15 showed significant M1-receptor affinity, indicating potential therapeutic applications.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- Quinuclidin-2-ene derivatives are explored for their pharmacological activities.
- Understanding muscarinic receptor interactions is crucial for drug development.
Purpose of the Study:
- To synthesize novel achiral 3-heteroaryl substituted quinuclidin-2-ene derivatives.
- To evaluate the muscarinic and antimuscarinic properties of these compounds.
Main Methods:
- Facile synthesis of quinuclidin-2-ene derivatives.
- Radioligand binding studies using (-)-[3H]-QNB to assess receptor affinity.
- Functional assays using isolated guinea pig urinary bladder to determine antimuscarinic effects.
Main Results:
- A series of novel compounds were successfully synthesized.
- Compound 15, 3-(2-Benzofuranyl)-quinuclidin-2-ene, exhibited the highest affinity for the M1-muscarinic receptor (Ki = 9.6 nM).
Conclusions:
- The synthesized quinuclidin-2-ene derivatives represent a promising class of compounds for targeting muscarinic receptors.
- Compound 15 is a potent M1-receptor ligand, warranting further investigation for potential therapeutic applications.